EDWARDS LIFESCIENCES CORPORATION (EW) FY2026 Q1 Balance Sheet

Balance Sheet

As of 2026-03-31

Swipe to see the full flow
EDWARDS LIFESCIENCES CORPORATION (EW) FY2026 Q1 Balance SheetBalance sheet as of 2026-03-31. The chart shows assets, liabilities and equity at that date.Current liabilities$1.41 BLiabilities$2.99 BCurrent assets$6.23 BNon-current liabilities$1.58 BAssets$13.32 BEquity$10.33 BGross equity(calculated)$18.06 BNon-current assets$7.09 BHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSCash and cash equivalentsShort-term investments (Note 5)Inventories (Note 2)Accounts receivable, net of allowances of $15.6 and $15.0, respectivelyOther current assetsOther receivablesPrepaid expensesProperty, plant, and equipment, netGoodwillOther intangible assets, netDeferred income taxesOther assets (Note 2)Long-term investments (Note 5)Operating lease right-of-use assetsAccrued and other liabilities (Note 2)Accounts payableOperating lease liabilitiesLong-term debtUncertain tax positionsOther liabilitiesOperating lease liabilitiesRetained earningsAdditional paid-in capitalCommon stock, $1.00 par value, 1,050.0 shares authorized, 660.0 and 658.7 shares issued, and 577.0 and 580.7 shares outstanding, respectivelyCurrent assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesEquityGross equity (calculated)Treasury stock, at cost, 83.0 and 78.0 shares, respectivelyAccumulated other comprehensive loss (Note 13)Current liabilitiesCurrent liabilities$1.41 BAccrued and other liabilities (Note 2)Accrued and other liabilities (Note 2)$1.20 BAccounts payableAccounts payable$181.10 MLiabilitiesLiabilities$2.99 BCash and cash equivalentsCash and cash equivalents$2.45 BOperating lease liabilitiesOperating lease liabilities$24.30 MCurrent assetsCurrent assets$6.23 BShort-term investments (Note 5)Short-term investments (Note 5)$1.23 BLong-term debtLong-term debt$598.50 MNon-current liabilitiesNon-current liabilities$1.58 BInventories (Note 2)Inventories (Note 2)$1.12 BUncertain tax positionsUncertain tax positions$555.40 MAssetsAssets$13.32 BAccounts receivable, net of allowances of $15.6 and $15.0, respectivelyAccounts receivable, net$775.70 MEquityEquity$10.33 BOther liabilitiesOther liabilities$350.70 MOther current assetsOther current assets$329.50 MOperating lease liabilitiesOperating lease liabilities$80.10 MGross equity (calculated)Gross equity(calculated)$18.06 BOther receivablesOther receivables$197.30 MPrepaid expensesPrepaid expenses$135.70 MProperty, plant, and equipment, netProperty, plant, and equipment, net$1.82 BNon-current assetsNon-current assets$7.09 BGoodwillGoodwill$1.82 BRetained earningsRetained earnings$14.62 BOther intangible assets, netOther intangible assets, net$1.23 BDeferred income taxesDeferred income taxes$1.10 BOther assets (Note 2)Other assets (Note 2)$738.90 MLong-term investments (Note 5)Long-term investments (Note 5)$285.60 MAdditional paid-in capitalAdditional paid-in capital$2.78 BOperating lease right-of-use assetsOperating lease right-of-use assets$99.30 MCommon stock, $1.00 par value, 1,050.0 shares authorized, 660.0 and 658.7 shares issued, and 577.0 and 580.7 shares outstanding, respectivelyCommon stock$660.00 MTreasury stock, at cost, 83.0 and 78.0 shares, respectivelyTreasury stock−$7.51 BAccumulated other comprehensive loss (Note 13)Accumulated other comprehensive loss (Note 13)−$221.30 M
Chart details

EDWARDS LIFESCIENCES CORPORATION (EW) FY2026 Q1 Balance Sheet

Balance sheet as of 2026-03-31. The chart shows assets, liabilities and equity at that date.

Assets
13,321,200,000 US dollars
Current assets
6,228,700,000 US dollars
Non-current assets
7,092,500,000 US dollars
Liabilities
2,993,700,000 US dollars
Current liabilities
1,409,000,000 US dollars
Non-current liabilities
1,584,700,000 US dollars
Equity
10,327,500,000 US dollars
Cash and cash equivalents
2,445,500,000 US dollars
Short-term investments (Note 5)
1,226,000,000 US dollars
Inventories (Note 2)
1,119,000,000 US dollars
Accounts receivable, net of allowances of $15.6 and $15.0, respectively
775,700,000 US dollars
Other current assets
329,500,000 US dollars
Other receivables
197,300,000 US dollars
Prepaid expenses
135,700,000 US dollars
Property, plant, and equipment, net
1,823,100,000 US dollars
Goodwill
1,819,600,000 US dollars
Other intangible assets, net
1,227,900,000 US dollars
Deferred income taxes
1,098,100,000 US dollars
Other assets (Note 2)
738,900,000 US dollars
Long-term investments (Note 5)
285,600,000 US dollars
Operating lease right-of-use assets
99,300,000 US dollars
Accrued and other liabilities (Note 2)
1,203,600,000 US dollars
Accounts payable
181,100,000 US dollars
Operating lease liabilities
24,300,000 US dollars
Long-term debt
598,500,000 US dollars
Uncertain tax positions
555,400,000 US dollars
Other liabilities
350,700,000 US dollars
Operating lease liabilities
80,100,000 US dollars
Retained earnings
14,621,200,000 US dollars
Additional paid-in capital
2,781,500,000 US dollars
Common stock, $1.00 par value, 1,050.0 shares authorized, 660.0 and 658.7 shares issued, and 577.0 and 580.7 shares outstanding, respectively
660,000,000 US dollars
Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding
0 US dollars
Treasury stock, at cost, 83.0 and 78.0 shares, respectively
negative 7,513,900,000 US dollars
Accumulated other comprehensive loss (Note 13)
negative 221,300,000 US dollars
Gross equity (calculated)
18,062,700,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
EDWARDS LIFESCIENCES CORPORATION (EW) FY2026 Q1 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!